Seeking Mandarin speakers for Henlius Biopharma
About Henlius
Henlius is a rapidly growing biopharmaceutical provider that develops, manufactures, and distributes leading biologics and mAb oncology treatments in more than 60 countries around the world, serving over 1,100,000 patients. Our mission is to improve patients’ lives by timely providing them with quality and affordable protein therapeutics through technical innovation and operational excellence.
Primary focus: Henlius develops biological oncology treatments for cancers with the highest prevalence rates and highest clinical needs, including breast, lung and gastrointestinal tumors and other solid tumors and hematology. Secondary focus: Henlius also develops biologics for non-oncology disorders including immune-mediated inflammatory disease and metabolic disorders.
Henlius has currently 4000+ employees, 1000 in R&D, and 800+with a Master’s degree or above, along with 42% female executives.
Henlius portfolio projects span from R&D Innovation, Clinical & Regulatory, Manufacturing & Quality to Enterprise Productivity & Decision-Making. From R&D to decision-making, AI covers the full drug lifecycle, solving different core problems per scenario to create differentiated value.